Illumina, Inc. (ILMN)
Track the next or latest earnings date for Illumina, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
www.tradingview.com · 4 days ago
Over the past year, this Zacks Rank #3 (Hold) stock has surged 87%, well ahead of the industry’s 23.8% growth and the S&P 500 composite’s rise of 22.8%. The renowned biotechnology company has a market capitalization of $27.82 billion. ILMN’s earnings yield of 2.8% is well ahead of the ...
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Downsides Amidst 33.82% ROEdirectorstalkinterviews.com · 1 day ago
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Downsides Amidst 33.82% ROE
Why Illumina (ILMN) Stock Is Trading Up Todayfinance.yahoo.com · 2 weeks ago
Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to its board and a price target increase from Barclays.
FinancialContent - Why Illumina (ILMN) Stock Is Down Todaymarkets.financialcontent.com · 1 week ago
Shares of genomics company Illumina (NASDAQ: ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation gene sequencing machine, taking aim at the company's market dominance.
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?finance.yahoo.com · April 30, 2026
TEM and ILMN battle in precision oncology, but stronger stock gains, valuation and earnings outlook position ILMN as the more compelling pick now.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: $1.20
Revenue estimate: N/A
Market cap: $17.99B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 05, 2026 | 2025-12-31 | Time not specified | $1.20 | N/A |